Journal
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
Volume 7, Issue 6, Pages 914-924Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.nano.2011.03.002
Keywords
Bone; Cytotoxicity; Internalization; In vivo; Nanoparticles; Stem cells
Funding
- Portuguese Foundation for Science and Technology (FCT) [PTDC/QUI/68804/2006]
- Canon Foundation in Europe
- European NoE EXPERTISSUES [NMP3-CT-2004-500283]
- HIPPOCRATES [NMP3-CT-2003-505758]
- Fundação para a Ciência e a Tecnologia [PTDC/QUI/68804/2006, SFRH/BD/132665/2017] Funding Source: FCT
Ask authors/readers for more resources
The control of stem cell differentiation to obtain osteoblasts in vivo is still regarded as a challenge in stem-cell-based and bone-tissue engineering strategies. Biodegradable dexamethasone-loaded dendron-like nanoparticles (NPs) of carboxymethylchitosan/poly(amidoamine) dendrimer have been proposed as intracellular drug-delivery systems of bioactive molecules. In this study, combination of nanotechnology, stem-cell engineering and tissue engineering is proposed in pre-programming the fate of rat bone marrow stromal cells (RBMSCs) towards osteoblasts cells and development of new bone tissue, in vivo. This work demonstrated that the developed NPs were able to be taken up by RBMSCs, and exhibited a noncytotoxic behavior in vitro. The performance of the developed dendronlike NP system for the intracellular delivery of dexamethasone was investigated by seeding the engineered RBMSCs onto starch-polycaprolactone scaffolds ex vivo, and implanting subcutaneously in the back of Fischer 344/N rats (Syngeneic), in the absence of the typical osteogenic supplements. Favorable results were observed in vivo, thus suggesting that stem cell tune-up strategy can open up a new regenerative strategy for bone-tissue engineering. From the Clinical Editor: In this study, a combination of nanotechnology, stem-cell engineering and tissue engineering is proposed in preprogramming the fate of rat bone marrow stromal cells (RBMSCs) towards osteoblasts cells and development of new bone tissue in vivo. (C) 2011 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available